Back to Journals » OncoTargets and Therapy » Volume 7 » default
OncoTargets and Therapy
ISSN: 1178-6930
- View all (6490)
- Volume 17, 2024 (52)
- Volume 16, 2023 (147)
- Volume 15, 2022 (191)
- Volume 14, 2021 (525)
- Volume 13, 2020 (1171)
- Volume 12, 2019 (1075)
- Volume 11, 2018 (882)
- Volume 10, 2017 (615)
- Volume 9, 2016 (802)
- Volume 8, 2015 (439)
- Volume 7, 2014 (253)
- Volume 6, 2013 (208)
- Volume 5, 2012 (54)
- Volume 4, 2011 (19)
- Volume 3, 2010 (22)
- Volume 2, 2009 (25)
- Volume 1, 2008 (10)
Archive: Volume 7, 2014
Induction of multiple drug resistance in HMEC-1 endothelial cells after long-term exposure to sunitinib
Huang LM, Hu CQ, Di Benedetto M, Varin R, Liu JL, Wang L, Vannier JP, Jin J, Janin A, Lu H, Li H
OncoTargets and Therapy 2014, 7:2249-2255
Published Date: 4 December 2014
Angiogenesis and antiangiogenic agents in cervical cancer
Tomao F, Papa A, Rossi L, Zaccarelli E, Caruso D, Zoratto F, Benedetti Panici P, Tomao S
OncoTargets and Therapy 2014, 7:2237-2248
Published Date: 3 December 2014
Microtubule inhibitor-based antibody–drug conjugates for cancer therapy
Klute K, Nackos E, Tasaki S, Nguyen DP, Bander NH, Tagawa ST
OncoTargets and Therapy 2014, 7:2227-2236
Published Date: 3 December 2014
Multidrug resistance protein 1 localization in lipid raft domains and prostasomes in prostate cancer cell lines
Gomà A, Mir R, Martínez-Soler F, Tortosa A, Vidal A, Condom E, Pérez–Tomás R, Giménez-Bonafé P
OncoTargets and Therapy 2014, 7:2215-2225
Published Date: 5 December 2014
Role of urokinase plasminogen activator and plasminogen activator inhibitor mRNA expression as prognostic factors in molecular subtypes of breast cancer
Witzel I, Milde-Langosch K, Schmidt M, Karn T, Becker S, Wirtz R, Rody A, Laakmann E, Schütze D, Jänicke F, Müller V
OncoTargets and Therapy 2014, 7:2205-2213
Published Date: 28 November 2014
EGF and EGFR genetic polymorphisms predict prognosis in locally advanced pharyngolaryngeal squamous cell carcinoma patients receiving postoperative concurrent chemoradiotherapy
Su NW, Leu YS, Lee JC, Liu CJ, Cheng CY, Lin JS, Chen YJ, Chen CK, Fang IC, Hsieh RK, Chang YF
OncoTargets and Therapy 2014, 7:2197-2204
Published Date: 28 November 2014
Doxorubicin-conjugated bacteriophages carrying anti-MHC class I chain-related A for targeted cancer therapy in vitro
Phumyen A, Jantasorn S, Jumnainsong A, Leelayuwat C
OncoTargets and Therapy 2014, 7:2183-2195
Published Date: 28 November 2014
Continuation of bevacizumab and addition of hormone therapy following weekly paclitaxel therapy in HER2-negative metastatic breast cancer
Redondo A, Martínez V, Zamora P, Castelo B, Pinto A, Cruz P, Higuera O, Mendiola M, Hardisson D, Espinosa E
OncoTargets and Therapy 2014, 7:2175-2181
Published Date: 27 November 2014
Cytologic surveillance versus immediate colposcopy for women with a cervical smear diagnosis of low-grade squamous intraepithelial lesion in a poor setting in Nigeria
Ajah LO, Chigbu CO, Onah HE, Iyoke CA, Lawani OL, Ezeonu PO
OncoTargets and Therapy 2014, 7:2169-2173
Published Date: 27 November 2014
The association of apoptotic protein expressions sensitive to apoptosis gene, p73 and p53 with the prognosis of cervical carcinoma
Mega Tiber P, Baloglu L, Ozden S, Ozgen Z, Ozyurt H, Eren M, Orun O
OncoTargets and Therapy 2014, 7:2161-2168
Published Date: 26 November 2014
Neoadjuvant chemotherapy in locally advanced cervical carcinoma: which is better, intravenous or intra-arterial?
Gui T, Shen K, Xiang Y, Pan LY, Lang JH, Wu M, Huang HF, Cao DY, Yang JX
OncoTargets and Therapy 2014, 7:2155-2160
Published Date: 26 November 2014
Impact of type 2 diabetes mellitus on the prognosis of early stage triple-negative breast cancer in People’s Republic of China
Ma FJ, Liu ZB, Qu L, Hao S, Liu GY, Wu J, Shao ZM
OncoTargets and Therapy 2014, 7:2147-2154
Published Date: 27 November 2014
FOLFIRI and regorafenib combination therapy with dose escalation of irinotecan as fourth-line treatment for patients with metastatic colon cancer according to UGT1A1 genotyping
Lu CY, Yeh YS, Huang CW, Ma CJ, Yu FJ, Wang JY
OncoTargets and Therapy 2014, 7:2143-2146
Published Date: 21 November 2014
Post-nephrectomy foreign-body granuloma in the retroperitoneum mimicking lymph node metastasis of renal cell cancer
Luo J, Mao Y, Cai S, Shen X, Chen S, Xie L
OncoTargets and Therapy 2014, 7:2137-2141
Published Date: 20 November 2014
Long-term complete remission in a patient with intravascular large B-cell lymphoma with central nervous system involvement
Sawada T, Omuro Y, Kobayashi T, Hishima T, Koizumi F, Kanemasa Y, Shimoyama T, Sasaki E, Maeda Y
OncoTargets and Therapy 2014, 7:2133-2136
Published Date: 18 November 2014
Comparison of clinical features, molecular alterations, and prognosis in morphological subgroups of lung invasive mucinous adenocarcinoma
Cai D, Li H, Wang R, Li Y, Pan YJ, Hu HC, Zhang Y, Gong RX, Pan B, Sun YH, Chen HQ
OncoTargets and Therapy 2014, 7:2127-2132
Published Date: 18 November 2014
Large malignant ovarian tumors during pregnancy: two cases
Xu D, Liang C, He J
OncoTargets and Therapy 2014, 7:2121-2125
Published Date: 17 November 2014
Topoisomerase II alpha and TLE3 as predictive markers of response to anthracycline and taxane-containing regimens for neoadjuvant chemotherapy in breast cancer
Susini T, Berti B, Carriero C, Tavella K, Nori J, Vanzi E, Molino C, Di Tommaso M, Santini M, Saladino V, Bianchi S
OncoTargets and Therapy 2014, 7:2111-2120
Published Date: 17 November 2014
Pelvis metastasis from primary choroidal melanoma: a case report
Xiong Y, Lang Y, Tu CQ, Duan H
OncoTargets and Therapy 2014, 7:2107-2110
Published Date: 14 November 2014
Natural history of histologically moderate cervical dysplasia in adolescent and young women
Piris S, Bravo V, Álvarez C, Muñoz-Hernando L, Lorenzo-Hernando E, Oliver R, Marqueta-Marques L, Seoane-Ruiz JM, Tejerizo-Garcia A, Jiménez JS
OncoTargets and Therapy 2014, 7:2101-2106
Published Date: 13 November 2014
Gemcitabine and oxaliplatinum: an effective regimen in patients with refractory and relapsing Hodgkin lymphoma
Gutierrez A, Rodriguez J, Martinez-Serra J, Gines J, Paredes P, Garcia F, Vercher J, Balanzat J, del Campo R, Galan P, Morey M, Sampol A, Novo A, Bento L, García L, Bargay J, Besalduch J
OncoTargets and Therapy 2014, 7:2093-2100
Published Date: 13 November 2014
Elevation of methylated DNA in KILLIN/PTEN in the plasma of patients with thyroid and/or breast cancer
Ng EK, Shin VY, Leung CP, Chan VW, Law FB, Siu MT, Lang BH, Ma ES, Kwong A
OncoTargets and Therapy 2014, 7:2085-2092
Published Date: 11 November 2014
EGFR-TKI therapy for patients with brain metastases from non-small-cell lung cancer: a pooled analysis of published data
Fan Y, Xu X, Xie C
OncoTargets and Therapy 2014, 7:2075-2084
Published Date: 10 November 2014
IL-1α -889 C/T polymorphism and cancer susceptibility: a meta-analysis
Cheng D, Hao Y, Zhou W
OncoTargets and Therapy 2014, 7:2067-2074
Published Date: 10 November 2014
Efficient utilization of EBUS-TBNA samples for both diagnosis and molecular analyses
Oezkan F, Khan AM, Zarogoulidis P, Hohenforst-Schmidt W, Theegarten D, Yasufuku K, Nakajima T, Freitag L, Darwiche K
OncoTargets and Therapy 2014, 7:2061-2065
Published Date: 10 November 2014
The effect of laughter therapy on radiation dermatitis in patients with breast cancer: a single-blind prospective pilot study
Kong M, Shin SH, Lee EM, Yun EK
OncoTargets and Therapy 2014, 7:2053-2059
Published Date: 4 November 2014
Clinical outcome of advanced and metastatic renal cell carcinoma treated with targeted therapy: is there a difference between young and old patients?
Zhang G, Zhu Y, Dong D, Gu W, Zhang H, Sun L, Ye D
OncoTargets and Therapy 2014, 7:2043-2052
Published Date: 3 November 2014
Antisense therapeutics in oncology: current status
Farooqi AA, Rehman ZU, Muntane J
OncoTargets and Therapy 2014, 7:2035-2042
Published Date: 3 November 2014
Proapoptotic and antiinvasive activity of Rac1 small molecule inhibitors on malignant glioma cells
Cardama GA, Gonzalez N, Ciarlantini M, Gandolfi Donadío L, Comin MJ, Alonso DF, Menna PL, Gomez DE
OncoTargets and Therapy 2014, 7:2021-2033
Published Date: 30 October 2014
The effects of ponatinib, a multi-targeted tyrosine kinase inhibitor, against human U87 malignant glioblastoma cells
Zhang J, Zhou Q, Gao G, Wang Y, Fang Z, Li G, Yu M, Kong L, Xing Y, Gao X
OncoTargets and Therapy 2014, 7:2013-2019
Published Date: 30 October 2014
Gli3 silencing enhances cyclopamine suppressive effects on ovarian cancer
Liu HY, Dong Z
OncoTargets and Therapy 2014, 7:2007-2011
Published Date: 30 October 2014
Ramucirumab: preclinical research and clinical development
Aprile G, Rijavec E, Fontanella C, Rihawi K, Grossi F
OncoTargets and Therapy 2014, 7:1997-2006
Published Date: 29 October 2014
Prognostic significance of CDH13 hypermethylation and mRNA in NSCLC
Xue R, Yang C, Zhao F, Li D
OncoTargets and Therapy 2014, 7:1987-1996
Published Date: 31 October 2014
B7-H3 expression in breast cancer and upregulation of VEGF through gene silence
Sun J, Guo YD, Li XN, Zhang YQ, Gu L, Wu PP, Bai GH, Xiao Y
OncoTargets and Therapy 2014, 7:1979-1986
Published Date: 29 October 2014
Profile of belinostat for the treatment of relapsed or refractory peripheral T-cell lymphoma
Bodiford A, Bodge M, Talbott MS, Reddy NM
OncoTargets and Therapy 2014, 7:1971-1977
Published Date: 24 October 2014
The transcription factor KLF4 as an independent predictive marker for pathologic complete remission in breast cancer neoadjuvant chemotherapy: a case–control study
Dong MJ, Wang LB, Jiang ZN, Jin M, Hu WX, Shen JG
OncoTargets and Therapy 2014, 7:1963-1969
Published Date: 24 October 2014
Downregulated Ku70 and ATM associated to poor prognosis in colorectal cancer among Chinese patients
Lu YF, Gao JY, Lu YM
OncoTargets and Therapy 2014, 7:1955-1961
Published Date: 24 October 2014
Ginsenoside Rg3 attenuates hepatoma VEGF overexpression after hepatic artery embolization in an orthotopic transplantation hepatocellular carcinoma rat model
Zhou B, Wang JH, Yan ZP
OncoTargets and Therapy 2014, 7:1945-1954
Published Date: 21 October 2014
Targeting the epithelial to mesenchymal transition in glioblastoma: the emerging role of MET signaling
Lee JK, Joo KM, Lee J, Yoon Y, Nam DH
OncoTargets and Therapy 2014, 7:1933-1944
Published Date: 20 October 2014
Angiopoietin 2 as a therapeutic target in hepatocellular carcinoma treatment: current perspectives
Bupathi M, Kaseb A, Janku F
OncoTargets and Therapy 2014, 7:1927-1932
Published Date: 20 October 2014
Metronomic capecitabine in gastroenteropancreatic neuroendrocrine tumors: a suitable regimen and review of the literature
Bongiovanni A, Riva N, Calpona S, Ricci M, Gunelli E, Liverani C, La Manna F, De Vita A, Monti M, Severi S, Pieri F, Amadori E, Galassi R, Cavaliere D, Zaccaroni A, Tartaglia A, Lunedei V, Gardini A, Mercatali L, Amadori D, Ibrahim T
OncoTargets and Therapy 2014, 7:1919-1926
Published Date: 20 October 2014
More than 9 years of continuous trastuzumab treatment in metastatic breast cancer without cardiac toxicity: a case report and literature review
Badulescu F, Badulescu A, Paul D, Popescu CF, Florescu C
OncoTargets and Therapy 2014, 7:1911-1917
Published Date: 17 October 2014
Clinical utility of recombinant adenoviral human p53 gene therapy: current perspectives
Chen GX, Zhang S, He XH, Liu SY, Ma C, Zou XP
OncoTargets and Therapy 2014, 7:1901-1909
Published Date: 21 October 2014
A survival analysis comparing women with ovarian low-grade serous carcinoma to those with high-grade histology
Chen M, Jin Y, Bi YL, Yin J, Wang YX, Pan LY
OncoTargets and Therapy 2014, 7:1891-1899
Published Date: 16 October 2014
Inhibition of Mus81 by siRNA enhances sensitivity to 5-FU in breast carcinoma cell lines
Qian Y, Liu YN, Yan QY, Lv J, Ni XY, Wu YL, Dong XJ
OncoTargets and Therapy 2014, 7:1883-1890
Published Date: 21 October 2014
Second-line docetaxel-based chemotherapy after failure of fluorouracil-based first-line treatment for advanced esophageal squamous cell carcinoma
Song ZB, Zhang YP
OncoTargets and Therapy 2014, 7:1875-1881
Published Date: 13 October 2014
Analysis of exfoliated gastric carcinoma cells attached on surgical supplies
Yu XF, Ma YY, Hu XQ, Zhang QF, Ye ZY
OncoTargets and Therapy 2014, 7:1869-1873
Published Date: 10 October 2014
Risk of treatment-related deaths with vascular endothelial growth factor receptor tyrosine kinase inhibitors: a meta-analysis of 41 randomized controlled trials
Hong SD, Fang WF, Liang WH, Yan Y, Zhou T, Qin T, Wu X, Ma YX, Zhao YY, Yang YP, Hu ZH, Xue C, Hou X, Chen Y, Huang Y, Zhao HY, Zhang L
OncoTargets and Therapy 2014, 7:1851-1867
Published Date: 7 October 2014
Obstructive jaundice caused by intraductal metastasis of lung adenocarcinoma
Ochi N, Goto D, Yamane H, Yamagishi T, Honda Y, Monobe Y, Kawamoto H, Takigawa N
OncoTargets and Therapy 2014, 7:1847-1850
Published Date: 7 October 2014
Profile of trebananib (AMG386) and its potential in the treatment of ovarian cancer
Liontos M, Lykka M, Dimopoulos MA, Bamias A
OncoTargets and Therapy 2014, 7:1837-1845
Published Date: 4 October 2014
Prognostic value of preoperative absolute lymphocyte count in recurrent hepatocellular carcinoma following thermal ablation: a retrospective analysis
Li X, Han ZY, Cheng ZG, Yu J, Yu XL, Liang P
OncoTargets and Therapy 2014, 7:1829-1835
Published Date: 3 October 2014
Colorectal cancer in Chinese patients: current and emerging treatment options
Li L, Ma BBY
OncoTargets and Therapy 2014, 7:1817-1828
Published Date: 4 October 2014
A new inflammation index is useful for patients with esophageal squamous cell carcinoma
Feng JF, Huang Y, Chen QX
OncoTargets and Therapy 2014, 7:1811-1815
Published Date: 30 September 2014
Study of the mechanism of sonodynamic therapy in a rat glioma model
Song D, Yue W, Li Z, Li J, Zhao J, Zhang N
OncoTargets and Therapy 2014, 7:1801-1810
Published Date: 30 September 2014
An evidence-based review of ixazomib citrate and its potential in the treatment of newly diagnosed multiple myeloma
Offidani M, Corvatta L, Caraffa P, Gentili S, Maracci L, Leoni P
OncoTargets and Therapy 2014, 7:1793-1800
Published Date: 29 September 2014
Capecitabine-induced cardiotoxicity: more evidence or clinical approaches to protect the patients' heart?
Fontanella C, Aita M, Cinausero M, Aprile G, Baldin MG, Dusi V, Lestuzzi C, Fasola G, Puglisi F
OncoTargets and Therapy 2014, 7:1783-1791
Published Date: 29 September 2014
The expression sequence tag is an effective method for screening DNA segments that predict urinary bladder transitional cell carcinoma prognosis
Yang PS, Hsu YC, Lin YH, Hou CP, Chen CL, Chang PL, Juang HH, Tsui KH
OncoTargets and Therapy 2014, 7:1777-1781
Published Date: 30 September 2014
Conventional fractionated helical tomotherapy for patients with small to medium hepatocellular carcinomas without portal vein tumor thrombosis
Jung J, Kong M, Hong SE
OncoTargets and Therapy 2014, 7:1769-1775
Published Date: 26 September 2014
Crenolanib, a PDGFR inhibitor, suppresses lung cancer cell proliferation and inhibits tumor growth in vivo
Wang P, Song L, Ge H, Jin P, Jiang Y, Hu W, Geng N
OncoTargets and Therapy 2014, 7:1761-1768
Published Date: 26 September 2014
Expression of YY1 correlates with progression and metastasis in esophageal squamous cell carcinomas
Luo J, Jiang X, Cao L, Dai K, Zhang S, Ge X, Zhou X, Lu X
OncoTargets and Therapy 2014, 7:1753-1759
Published Date: 26 September 2014
Prognostic value of preoperative inflammatory markers in Chinese patients with breast cancer
Yao MY, Liu Y, Jin HL, Liu XJ, Lv KZ, Wei HY, Du CY, Wang SQ, Wei BJ, Fu PF
OncoTargets and Therapy 2014, 7:1743-1752
Published Date: 26 September 2014
Overexpression of ETV4 protein in triple-negative breast cancer is associated with a higher risk of distant metastasis
Yuan ZY, Dai T, Wang SS, Peng RJ, Li XH, Qin T, Song LB, Wang X
OncoTargets and Therapy 2014, 7:1733-1742
Published Date: 26 September 2014
PTK7 as a potential prognostic and predictive marker of response to adjuvant chemotherapy in breast cancer patients, and resistance to anthracycline drugs
Ataseven B, Gunesch A, Eiermann W, Kates RE, Högel B, Knyazev P, Ullrich A, Harbeck N
OncoTargets and Therapy 2014, 7:1723-1731
Published Date: 6 October 2014
Brentuximab vedotin for relapsed or refractory CD30+ Hodgkin lymphoma: a multicenter analysis from Asia
Yang QM, Hong JY, Ko YH, Lin SY, Au WY, Choi MK, Park S, Kim SJ, Kim WS
OncoTargets and Therapy 2014, 7:1717-1722
Published Date: 26 September 2014
Tumor heterogeneity in the recurrence of epithelial ovarian cancer demonstrated by polycomb group proteins
Gui T, Bai HM, Zeng JF, Zhong ZJ, Cao DY, Cui QC, Chen J, Yang JX, Shen K
OncoTargets and Therapy 2014, 7:1705-1716
Published Date: 25 September 2014
Tumor heterogeneity and resistance to EGFR-targeted therapy in advanced nonsmall cell lung cancer: challenges and perspectives
Cheng X, Chen H
OncoTargets and Therapy 2014, 7:1689-1704
Published Date: 23 September 2014
The emerging role of class-3 semaphorins and their neuropilin receptors in oncology
Nasarre P, Gemmill RM, Drabkin HA
OncoTargets and Therapy 2014, 7:1663-1687
Published Date: 24 September 2014
Clinical significance of UGT1A1 gene polymorphisms on irinotecan-based regimens as the treatment in metastatic colorectal cancer
Li MM, Wang ZH, Guo J, Liu J, Li CZ, Liu L, Shi H, Liu LY, Li HH, Xie C, Zhang X, Sun WW, Fang S, Bi X
OncoTargets and Therapy 2014, 7:1653-1661
Published Date: 23 September 2014
The target therapy of ovarian clear cell carcinoma
Jin Y, Li Y, Pan LY
OncoTargets and Therapy 2014, 7:1647-1652
Published Date: 23 September 2014
Cyclophosphamide-induced symptomatic hyponatremia, a rare but severe side effect: a case report
Elazzazy S, Mohamed AE, Gulied A
OncoTargets and Therapy 2014, 7:1641-1645
Published Date: 30 September 2014
Profile of selumetinib and its potential in the treatment of melanoma
Kim DW, Patel SP
OncoTargets and Therapy 2014, 7:1631-1639
Published Date: 19 September 2014
Expression and clinical significance of the long non-coding RNA PVT1 in human gastric cancer
Ding J, Li D, Gong M, Wang J, Huang X, Wu T, Wang C
OncoTargets and Therapy 2014, 7:1625-1630
Published Date: 18 September 2014
Nanotetrac targets integrin αvβ3 on tumor cells to disorder cell defense pathways and block angiogenesis
Davis PJ, Lin HY, Sudha T, Yalcin M, Tang HY, Hercbergs A, Leith JT, Luidens MK, Ashur-Fabian O, Incerpi S, Mousa SA
OncoTargets and Therapy 2014, 7:1619-1624
Published Date: 18 September 2014
Isolation, detection, and immunomorphological characterization of circulating tumor cells (CTCs) from patients with different types of sarcoma using isolation by size of tumor cells: a window on sarcoma-cell invasion
Chinen LTD, Mello CAL, Abdallah EA, Ocea LMM, Buim ME, Breve NM, Gasparini Junior JL, Fanelli MF, Paterlini-Bréchot P
OncoTargets and Therapy 2014, 7:1609-1617
Published Date: 16 September 2014
Upregulation of micro-ribonucleic acid-128 cooperating with downregulation of PTEN confers metastatic potential and unfavorable prognosis in patients with primary osteosarcoma
Tian Z, Guo B, Yu M, Wang C, Zhang H, Liang Q, Jiang K, Cao L
OncoTargets and Therapy 2014, 7:1601-1608
Published Date: 15 September 2014
Arsenic trioxide-based therapy in relapsed/refractory multiple myeloma patients: a meta-analysis and systematic review
He XP, Yang K, Chen P, Liu B, Zhang Y, Wang F, Guo Z, Liu XD, Lou JX, Chen HR
OncoTargets and Therapy 2014, 7:1593-1599
Published Date: 10 September 2014
MiR-206 functions as a tumor suppressor and directly targets K-Ras in human oral squamous cell carcinoma
Lin FO, Yao LJ, Xiao J, Liu DF, Ni ZY
OncoTargets and Therapy 2014, 7:1583-1591
Published Date: 11 September 2014
Antiangiogenic cancer drug sunitinib exhibits unexpected proangiogenic effects on endothelial cells
Norton KA, Han ZY, Popel AS, Pandey NB
OncoTargets and Therapy 2014, 7:1571-1582
Published Date: 9 September 2014
HIF1α is an independent prognostic factor for overall survival in advanced primary epithelial ovarian cancer – a study of the OVCAD Consortium
Braicu EI, Luketina H, Richter R, Cacsire Castillo-Tong D, Lambrechts S, Mahner S, Concin N, Mentze M, Zeillinger R, Vergote I, Sehouli J
OncoTargets and Therapy 2014, 7:1563-1569
Published Date: 11 September 2014
Bevacizumab in Japanese patients with malignant glioma: from basic research to clinical trial
Takano S, Ishikawa E, Nakai K, Matsuda M, Masumoto T, Yamamoto T, Matsumura A
OncoTargets and Therapy 2014, 7:1551-1562
Published Date: 5 September 2014
Bupivacaine administered intrathecally versus rectally in the management of intractable rectal cancer pain in palliative care
Zaporowska-Stachowiak I, Kowalski G, Łuczak J, Kosicka K, Kotlinska-Lemieszek A, Sopata M, Główka F
OncoTargets and Therapy 2014, 7:1541-1550
Published Date: 6 October 2014
An individual drug-therapy and genetic testing report of temporal bone verrucous carcinoma
Tan HL, Liu Y, Zhu GC, Pi LM, Huang DH, Zhang X
OncoTargets and Therapy 2014, 7:1535-1540
Published Date: 4 September 2014
ER-α36: a novel biomarker and potential therapeutic target in breast cancer
Su XY, Xu X, Li GL, Lin BY, Cao J, Teng LS
OncoTargets and Therapy 2014, 7:1525-1533
Published Date: 30 August 2014
Long-term outcomes from dose-escalated image-guided intensity-modulated radiotherapy with androgen deprivation: encouraging results for intermediate- and high-risk prostate cancer
Wilcox SW, Aherne NJ, Benjamin LC, Wu B, de Campos Silva T, McLachlan CS, McKay MJ, Last AJ, Shakespeare TP
OncoTargets and Therapy 2014, 7:1519-1523
Published Date: 30 August 2014
Cytoprotection “gone astray’’: Nrf2 and its role in cancer
Geismann C, Arlt A, Sebens S, Schäfer H
OncoTargets and Therapy 2014, 7:1497-1518
Published Date: 26 August 2014
The involvement of Kras gene 3'-UTR polymorphisms in risk of cancer and influence on patient response to anti-EGFR therapy in metastatic colorectal cancer: a meta-analysis
Ying HQ, Wang F, He BS, Pan YQ, Gao TY, Xu YQ, Li R, Deng QW, Sun HL, Wang SK
OncoTargets and Therapy 2014, 7:1487-1496
Published Date: 25 August 2014
miR-129 as a novel therapeutic target and biomarker in gastrointestinal cancer
Fesler A, Zhai H, Ju J
OncoTargets and Therapy 2014, 7:1481-1485
Published Date: 21 August 2014
High infiltration of tumor-associated macrophages in triple-negative breast cancer is associated with a higher risk of distant metastasis
Yuan ZY, Luo RZ, Peng RJ, Wang SS, Xue C
OncoTargets and Therapy 2014, 7:1475-1480
Published Date: 21 August 2014
Bevacizumab in combination with chemotherapy in platinum-sensitive ovarian cancer [Corrigendum]
Della Pepa C, Banerjee S
OncoTargets and Therapy 2014, 7:1473-1474
Published Date: 20 August 2014
The coexpression and clinical significance of costimulatory molecules B7-H1, B7-H3, and B7-H4 in human pancreatic cancer
Chen Y, Sun J, Zhao H, Zhu DM, Zhi QM, Song SD, Zhang LF, He SB, Kuang YT, Zhang ZX, Li DC
OncoTargets and Therapy 2014, 7:1465-1472
Published Date: 19 August 2014
A simple in vitro method for evaluating dendritic cell-based vaccinations
Pham PV, Nguyen NT, Nguyen HM, Khuat LT, Le PM, Pham VQ, Nguyen ST, Phan NK
OncoTargets and Therapy 2014, 7:1455-1464
Published Date: 18 August 2014
Glucagonoma syndrome: a case report with focus on skin disorders
Fang S, Li S, Cai T
OncoTargets and Therapy 2014, 7:1449-1453
Published Date: 14 August 2014
Isothermal multiple displacement amplification: a methodical approach enhancing molecular routine diagnostics of microcarcinomas and small biopsies
Mairinger FD, Walter RFH, Vollbrecht C, Hager T, Worm K, Ting S, Wohlschläger J, Zarogoulidis P, Zarogoulidis K, Schmid KW
OncoTargets and Therapy 2014, 7:1441-1447
Published Date: 13 August 2014
Sam68 is a novel marker for aggressive neuroblastoma [Corrigendum]
Zhao XH, Li ZQ, He BF, Liu JC, Li SS, Zhou L, Pan CL, Yu Z, Xu Z
OncoTargets and Therapy 2014, 7:1439-1440
Published Date: 14 August 2014
Oncogenic mutations are associated with histological subtypes but do not have an independent prognostic value in lung adenocarcinoma
Hu H, Pan Y, Li Y, Wang L, Wang R, Zhang Y, Li H, Ye T, Zhang Y, Luo X, Shao L, Sun Z, Cai D, Xu J, Lu Q, Deng Y, Shen L, Ji H, Sun Y, Chen H
OncoTargets and Therapy 2014, 7:1423-1437
Published Date: 13 August 2014
Initial LDH level can predict the survival benefit from bevacizumab in the first-line setting in Chinese patients with metastatic colorectal cancer
Yin CX, Jiang C, Liao FX, Rong YM, Cai XY, Guo GF, Qiu HJ, Chen XX, Zhang B, He WZ, Xia LP
OncoTargets and Therapy 2014, 7:1415-1422
Published Date: 11 August 2014
Outcomes analysis of an alternative formulation of PEGylated liposomal doxorubicin in recurrent epithelial ovarian carcinoma during the drug shortage era
Berger JL, Smith A, Zorn KK, Sukumvanich P, Olawaiye AB, Kelley J, Krivak TC
OncoTargets and Therapy 2014, 7:1409-1413
Published Date: 8 August 2014
PKN1 modulates TGFß and EGF signaling in HEC-1-A endometrial cancer cell line
Attarha S, Saini RK, Andersson S, Mints M, Souchelnytskyi S
OncoTargets and Therapy 2014, 7:1397-1408
Published Date: 4 August 2014
Silencing B7-H1 enhances the anti-tumor effect of bladder cancer antigen-loaded dendritic cell vaccine in vitro
Wang S, Wang YH, Liu J, Shao SX, Li XJ, Gao JN, Niu HT, Wang XS
OncoTargets and Therapy 2014, 7:1389-1396
Published Date: 5 August 2014
Potential implications of GRP58 expression and susceptibility of cervical cancer to cisplatin and thymoquinone-based therapy
Hafiza WAGWN, Latifah SY
OncoTargets and Therapy 2014, 7:1375-1387
Published Date: 7 August 2014
Lapatinib for the treatment of breast cancer in the People’s Republic of China
Wang HJ
OncoTargets and Therapy 2014, 7:1367-1373
Published Date: 31 July 2014
Paclitaxel- and/or cisplatin-induced ocular neurotoxicity: a case report and literature review
Li Y, Li YP, Li JY, Pi GL, Tan WY
OncoTargets and Therapy 2014, 7:1361-1366
Published Date: 31 July 2014
PD-1 as an emerging therapeutic target in renal cell carcinoma: current evidence
Tykodi SS
OncoTargets and Therapy 2014, 7:1349-1359
Published Date: 25 July 2014
Comparison of short-term effect of thoracoscopic segmentectomy and thoracoscopic lobectomy for the solitary pulmonary nodule and early-stage lung cancer
Ren MM, Meng QJ, Zhou WY, Kong FY, Yang B, Yuan J, Wu DW, Zhang J, Li QQ, Lin YS, Viswanathan VB, Song X
OncoTargets and Therapy 2014, 7:1343-1347
Published Date: 24 July 2014
External iliac vein – transplant ureteral fistula combined with renal cell carcinoma: an unusual case of hematuria
Luo JD, Liu B, Wang P, Zhou F, Xu XL, Li SQ, Cai SL, Wang YM
OncoTargets and Therapy 2014, 7:1339-1342
Published Date: 23 July 2014
MicroRNAs transported by exosomes in body fluids as mediators of intercellular communication in cancer
Salido-Guadarrama I, Romero-Cordoba S, Peralta-Zaragoza O, Hidalgo-Miranda A, Rodríguez-Dorantes M
OncoTargets and Therapy 2014, 7:1327-1338
Published Date: 21 July 2014
High expression of HEF1 is associated with poor prognosis in urinary bladder carcinoma
Zhang Q, Wang HJ, Zhang DH, Ru GQ, He XJ, Ma YY
OncoTargets and Therapy 2014, 7:1319-1326
Published Date: 21 July 2014
Circulating tumor cells in the central and peripheral venous compartment – assessing hematogenous dissemination after transarterial chemoembolization of hepatocellular carcinoma
Fang ZT, Zhang W, Wang GZ, Zhou B, Yang GW, Qu XD, Liu R, Qian S, Zhu L, Liu LX, Wang JH
OncoTargets and Therapy 2014, 7:1311-1318
Published Date: 18 July 2014
Prognostic significance of thymidylate synthase in postoperative non-small cell lung cancer patients
Zhao HY, Ma GW, Zou BY, Li M, Lin SX, Zhao LP, Guo Y, Huang Y, Tian Y, Xie D, Zhang L
OncoTargets and Therapy 2014, 7:1301-1310
Published Date: 16 July 2014
Sorafenib in radioactive iodine-refractory well-differentiated metastatic thyroid cancer
McFarland DC, Misiukiewicz KJ
OncoTargets and Therapy 2014, 7:1291-1299
Published Date: 15 July 2014
Salivary expression of soluble HER2 in breast cancer patients with positive and negative HER2 status
Laidi F, Bouziane A, Lakhdar A, Khabouze S, Rhrab B, Zaoui F
OncoTargets and Therapy 2014, 7:1285-1289
Published Date: 14 July 2014
Clinical utility of trabectedin for the treatment of ovarian cancer: current evidence
Mascilini F, Amadio G, Di Stefano MG, Ludovisi M, Di Legge A, Conte C, De Vincenzo R, Ricci C, Masciullo V, Salutari V, Scambia G, Ferrandina G
OncoTargets and Therapy 2014, 7:1273-1284
Published Date: 12 July 2014
Discordance rate of HER2 status in primary breast carcinomas versus synchronous axillary lymph node metastases: a multicenter retrospective investigation
Ieni A, Barresi V, Caltabiano R, Cascone AM, Del Sordo R, Cabibi D, Zeppa P, Lanzafame S, Sidoni A, Franco V, Tuccari G
OncoTargets and Therapy 2014, 7:1267-1272
Published Date: 11 July 2014
Randomized double-blind trial of prophylactic topical Evozac® Calming Skin Spray for gefitinib-associated acne-like eruption
Wang Y, Yang Y, Xu J, Yu J, Liu X, Gao R, Zhang L
OncoTargets and Therapy 2014, 7:1261-1266
Published Date: 10 July 2014
Lack of association between the XPD Lys751Gln polymorphism and colorectal cancer risk: a meta-analysis
Zhang T, Zhang DM, Zhao D, Hou XM, Ma SC, Liu XJ
OncoTargets and Therapy 2014, 7:1255-1260
Published Date: 12 July 2014
Role of calcium-dependent protein kinases in chronic myeloid leukemia: combined effects of PKC and BCR-ABL signaling on cellular alterations during leukemia development
Mencalha AL, Corrêa S, Abdelhay E
OncoTargets and Therapy 2014, 7:1247-1254
Published Date: 8 July 2014
Clinical significance and association of RUNX3 hypermethylation frequency with colorectal cancer: a meta-analysis
Mu WP, Wang J, Niu Q, Shi N, Lian HF
OncoTargets and Therapy 2014, 7:1237-1245
Published Date: 10 July 2014
Targeted drug delivery via folate receptors in recurrent ovarian cancer: a review
Marchetti C, Palaia I, Giorgini M, De Medici C, Iadarola R, Vertechy L, Domenici L, Di Donato V, Tomao F, Muzii L, Benedetti Panici P
OncoTargets and Therapy 2014, 7:1223-1236
Published Date: 10 July 2014
CP-673451, a platelet-derived growth-factor receptor inhibitor, suppresses lung cancer cell proliferation and migration
Xi YL, Chen M, Liu XM, Lu ZM, Ding Y, Li DT
OncoTargets and Therapy 2014, 7:1215-1221
Published Date: 3 July 2014
Histological type-specific prognostic factors of cervical small cell neuroendocrine carcinoma, adenocarcinoma, and squamous cell carcinoma
Intaraphet S, Kasatpibal N, Søgaard M, Khunamornpong S, Patumanond J, Chandacham A, Chitapanarux I, Siriaunkgul S
OncoTargets and Therapy 2014, 7:1205-1214
Published Date: 1 July 2014
Expression profiles and initial confirmation of long noncoding RNAs in Chinese patients with pulmonary adenocarcinoma
Zhao X, Zhu W, Zha W, Chen F, Wu Z, Liu Y, Huang M
OncoTargets and Therapy 2014, 7:1195-1204
Published Date: 1 July 2014
Correlation between EGFR mutation status and response to first-line platinum-based chemotherapy in patients with advanced non-small cell lung cancer
Fang S, Wang ZH, Guo J, Liu J, Li CZ, Liu L, Shi H, Liu LY, Li HH, Xie C, Zhang X, Sun WW, Li MM
OncoTargets and Therapy 2014, 7:1185-1193
Published Date: 1 July 2014
A single-institution experience with bevacizumab in the treatment of metastatic colorectal cancer and in conjunction with liver resection
Osterlund P, Peltonen R, Alanko T, Bono P, Isoniemi H
OncoTargets and Therapy 2014, 7:1177-1184
Published Date: 1 July 2014
Modeling pegylated liposomal doxorubicin-induced hand-foot syndrome and intestinal mucositis in zebrafish
Chen YH, Lee YT, Wen CC, Chen YC, Chen YJ
OncoTargets and Therapy 2014, 7:1169-1175
Published Date: 1 July 2014
Clinicopathological and biological significance of aberrant activation of glycogen synthase kinase-3 in ovarian cancer
Fu Y, Wang X, Cheng X, Ye F, Xie X, Lu W
OncoTargets and Therapy 2014, 7:1159-1168
Published Date: 25 June 2014
Mapping lymph nodes in cancer management – role of 99mTc-tilmanocept injection
Tausch C, Baege A, Rageth C
OncoTargets and Therapy 2014, 7:1151-1158
Published Date: 24 June 2014
Integration of multidisciplinary technologies for real time target visualization and verification for radiotherapy
Chang WC, Chen CS, Tai HC, Liu CY, Chen YJ
OncoTargets and Therapy 2014, 7:1143-1150
Published Date: 23 June 2014
Clinical analysis of 13 males with primary choriocarcinoma and review of the literature
Jiang F, Xiang Y, Feng FZ, Ren T, Cui ZM, Wan XR
OncoTargets and Therapy 2014, 7:1135-1141
Published Date: 20 June 2014
Stemness and plasticity of lung cancer cells: paving the road for better therapy
Luo JD, Zhou XF, Yakisich JS
OncoTargets and Therapy 2014, 7:1129-1134
Published Date: 23 June 2014
Combination therapy with brentuximab vedotin and cisplatin/cytarabine in a patient with primarily refractory anaplastic lymphoma kinase positive anaplastic large cell lymphoma
Heidegger S, Beer AJ, Geissinger E, Rosenwald A, Peschel C, Ringshausen I, Keller U
OncoTargets and Therapy 2014, 7:1123-1127
Published Date: 20 June 2014
Neoadjuvant therapy for locally advanced melanoma: new strategies with targeted therapies
La Greca M, Grasso G, Antonelli G, Russo AE, Bartolotta S, D’Angelo A, Vitale FV, Ferraù F
OncoTargets and Therapy 2014, 7:1115-1121
Published Date: 19 June 2014
Recall radiation dermatitis by sorafenib following stereotactic body radiation therapy
Hsieh CH, Lin SC, Shueng PW, Kuo DY
OncoTargets and Therapy 2014, 7:1111-1114
Published Date: 18 June 2014
Progression-free survival as a potential surrogate for overall survival in metastatic breast cancer
Beauchemin C, Cooper D, Lapierre ME, Yelle L, Lachaine J
OncoTargets and Therapy 2014, 7:1101-1110
Published Date: 18 June 2014
Potential role of daratumumab in the treatment of multiple myeloma
Khagi Y, Mark TM
OncoTargets and Therapy 2014, 7:1095-1100
Published Date: 18 June 2014
ID2 predicts poor prognosis in breast cancer, especially in triple-negative breast cancer, and inhibits E-cadherin expression
Li K, Yao L, Chen L, Cao ZG, Yu SJ, Kuang XY, Hu X, Shao ZM
OncoTargets and Therapy 2014, 7:1083-1094
Published Date: 18 June 2014
Pilot study of intratumoral injection of recombinant heat shock protein 70 in the treatment of malignant brain tumors in children
Shevtsov MA, Kim AV, Samochernych KA, Romanova IV, Margulis BA, Guzhova IV, Yakovenko IV, Ischenko AM, Khachatryan WA
OncoTargets and Therapy 2014, 7:1071-1081
Published Date: 18 June 2014
HCA519/TPX2: a potential T-cell tumor-associated antigen for human hepatocellular carcinoma
Aref AM, Hoa NT, Ge L, Agrawal A, Dacosta-Iyer M, Lambrecht N, Ouyang Y, Cornforth AN, Jadus MR
OncoTargets and Therapy 2014, 7:1061-1070
Published Date: 13 June 2014
Nimotuzumab plus chemotherapy versus chemotherapy alone in advanced non-small-cell lung cancer: a multicenter, randomized, open-label Phase II study
Babu KG, Prabhash K, Vaid AK, Sirohi B, Diwakar RB, Rao R, Kar M, Malhotra H, Nag S, Goswami C, Raina V, Mohan R
OncoTargets and Therapy 2014, 7:1051-1060
Published Date: 13 June 2014
Myelodysplastic disorders carrying both isolated del(5q) and JAK2V617F mutation: concise review, with focus on lenalidomide therapy
Musto P, Simeon V, Guariglia R, Bianchino G, Grieco V, Nozza F, La Rocca F, Marziano G, Lalinga AV, Fabiani E, Voso MT, Scaravaglio P, Mecucci C, D'Arena G
OncoTargets and Therapy 2014, 7:1043-1050
Published Date: 13 June 2014
Gemcitabine resistance in breast cancer cells regulated by PI3K/AKT-mediated cellular proliferation exerts negative feedback via the MEK/MAPK and mTOR pathways
Yang XL, Lin FJ, Guo YJ, Shao ZM, Ou ZL
OncoTargets and Therapy 2014, 7:1033-1042
Published Date: 13 June 2014
Bevacizumab in combination with chemotherapy in platinum-sensitive ovarian cancer
Della Pepa C, Banerjee S
OncoTargets and Therapy 2014, 7:1025-1032
Published Date: 19 June 2014
Chemotherapy-enhanced inflammation may lead to the failure of therapy and metastasis
Vyas D, Laput G, Vyas AK
OncoTargets and Therapy 2014, 7:1015-1023
Published Date: 12 June 2014
Emerging molecular targets in oncology: clinical potential of MET/hepatocyte growth-factor inhibitors
Smyth EC, Sclafani F, Cunningham D
OncoTargets and Therapy 2014, 7:1001-1014
Published Date: 12 June 2014
Single incision versus conventional laparoscopic resection in gastrointestinal stromal tumors: a retrospective cohort analysis at a single tertiary care center
Kong J, Wu SD, Su Y, Fan Y
OncoTargets and Therapy 2014, 7:995-999
Published Date: 12 June 2014
xCELLigence system for real-time label-free monitoring of growth and viability of cell lines from hematological malignancies
Martinez-Serra J, Gutierrez A, Muñoz-Capó S, Navarro-Palou M, Ros T, Amat JC, Lopez B, Marcus TF, Fueyo L, Suquia AG, Gines J, Rubio F, Ramos R, Besalduch J
OncoTargets and Therapy 2014, 7:985-994
Published Date: 12 June 2014
The potential roles of hepatocyte growth factor (HGF)-MET pathway inhibitors in cancer treatment
Parikh RA, Wang P, Beumer JH, Chu E, Appleman LJ
OncoTargets and Therapy 2014, 7:969-983
Published Date: 11 June 2014
Paraganglioma of the vagina: a case report and review of the literature
Cai T, Li YC, Jiang QM, Wang D, Huang Y
OncoTargets and Therapy 2014, 7:965-968
Published Date: 10 June 2014
Prognosis of patients with hepatocellular carcinoma and hypersplenism after surgery: a single-center experience from the People's Republic of China
Li C, Zhao H, Zhao J, Li Z, Huang Z, Zhang Y, Bi X, Cai J
OncoTargets and Therapy 2014, 7:957-964
Published Date: 9 June 2014
Antitumor activity of total flavonoids from Tetrastigma hemsleyanum Diels et Gilg is associated with the inhibition of regulatory T cells in mice
Feng Z, Hao W, Lin X, Fan D, Zhou J
OncoTargets and Therapy 2014, 7:947-956
Published Date: 9 June 2014
Critical appraisal of pemetrexed in the treatment of NSCLC and metastatic pulmonary nodules
Li X, Wei S, Chen J
OncoTargets and Therapy 2014, 7:937-945
Published Date: 6 June 2014
Critical appraisal of sorafenib in the treatment of Chinese patients with renal cell carcinoma
Ye DW, Zhang HL
OncoTargets and Therapy 2014, 7:925-935
Published Date: 6 June 2014
Stereotactic body radiation therapy using the CyberKnife® system for patients with liver metastases
Yuan ZY, Meng MB, Liu CL, Wang HH, Jiang C, Song YC, Zhuang HQ, Yang D, Wang JS, Wei W, Li FT, Zhao LJ, Wang P
OncoTargets and Therapy 2014, 7:915-923
Published Date: 12 June 2014
Effect of NQO1 C609T polymorphism on prostate cancer risk: a meta-analysis
Zhang Q, Zheng M, Qi XL, Liu F, Mao ZJ, Zhang DH
OncoTargets and Therapy 2014, 7:907-914
Published Date: 5 June 2014
The potential clinical applications and prospects of microRNAs in lung cancer
Gao Y, Gao F, Ma JL, Sun WZ, Song LP
OncoTargets and Therapy 2014, 7:901-906
Published Date: 4 June 2014
miR-544a promotes the invasion of lung cancer cells by targeting cadherina 1 in vitro
Mo X, Zhang F, Liang H, Liu M, Li H, Xia H
OncoTargets and Therapy 2014, 7:895-900
Published Date: 4 June 2014
High expression of 23 kDa protein of augmenter of liver regeneration (ALR) in human hepatocellular carcinoma
Yu HY, Zhu MH, Xiang DR, Li J, Sheng JF
OncoTargets and Therapy 2014, 7:887-893
Published Date: 2 June 2014
Overexpression of Abl2 predicts poor prognosis in hepatocellular carcinomas and is associated with cancer cell migration and invasion
Xing QT, Qu CM, Wang G
OncoTargets and Therapy 2014, 7:881-885
Published Date: 30 May 2014
Cyclic adenosine monophosphate-responsive element-binding protein activation predicts an unfavorable prognosis in patients with hepatocellular carcinoma
Yu L, Guo X, Zhang P, Qi R, Li Z, Zhang S
OncoTargets and Therapy 2014, 7:873-879
Published Date: 29 May 2014
Pixantrone for the treatment of adult patients with relapsed or refractory aggressive non-Hodgkin B-cell lymphomas
Volpetti S, Zaja F, Fanin R
OncoTargets and Therapy 2014, 7:865-872
Published Date: 29 May 2014
Clinical significance of promoter region hypermethylation of microRNA-148a in gastrointestinal cancers
Sun JX, Song YX, Wang ZN, Wang GL, Gao P, Chen XW, Gao ZH, Xu HM
OncoTargets and Therapy 2014, 7:853-863
Published Date: 28 May 2014
Critical appraisal of the role of gefitinib in the management of locally advanced or metastatic non-small cell lung cancer
Yuan Y, Li XF, Chen JQ, Dong CX, Weng SS, Huang JJ
OncoTargets and Therapy 2014, 7:841-852
Published Date: 28 May 2014
Cerium oxide nanoparticles in cancer
Gao Y, Chen K, Ma JL, Gao F
OncoTargets and Therapy 2014, 7:835-840
Published Date: 27 May 2014
Serial changes of clinical parameters in a patient with advanced hepatocellular carcinoma with portal vein thrombosis achieving complete response after treatment with sorafenib
Kee KM, Hung CH, Wang JH, Lu SN
OncoTargets and Therapy 2014, 7:829-834
Published Date: 27 May 2014
Comprehensive clinical and pathological analysis of aggressive renal epithelioid angiomyolipoma: report of three cases
Luo J, Liu B, Wang Y, Li J, Wang P, Chen J, Wang C
OncoTargets and Therapy 2014, 7:823-827
Published Date: 27 May 2014
Prevalence and relationship between major depressive disorder and lung cancer: a cross-sectional study
Maneeton B, Maneeton N, Reungyos J, Intaprasert S, Leelarphat S, Thongprasert S
OncoTargets and Therapy 2014, 7:815-821
Published Date: 27 May 2014
Preliminary analysis of the risk factors for radiation pneumonitis in patients with non- small-cell lung cancer treated with concurrent erlotinib and thoracic radiotherapy
Zhuang H, Hou H, Yuan Z, Wang J, Pang Q, Zhao L, Wang P
OncoTargets and Therapy 2014, 7:807-813
Published Date: 24 May 2014
Prior EGFR tyrosine-kinase inhibitor therapy did not influence the efficacy of subsequent pemetrexed plus platinum in advanced chemonaïve patients with EGFR-mutant lung adenocarcinoma
Tseng JS, Yang TY, Chen KC, Hsu KH, Yu CJ, Liao WY, Tsai CR, Tsai MH, Yu SL, Su KY, Chen JJ, Chen HY, Chang GC
OncoTargets and Therapy 2014, 7:799-805
Published Date: 23 May 2014
Positron emission tomographic monitoring of dual phosphatidylinositol-3-kinase and mTOR inhibition in anaplastic large cell lymphoma
Graf N, Li ZL, Herrmann K, Weh D, Aichler M, Slawska J, Walch A, Peschel C, Schwaiger M, Buck AK, Dechow T, Keller U
OncoTargets and Therapy 2014, 7:789-798
Published Date: 23 May 2014
Preparation and functional studies of hydroxyethyl chitosan nanoparticles loaded with anti-human death receptor 5 single-chain antibody
Yang J, Huang X, Luo F, Cheng X, Cheng L, Liu B, Chen L, Hu R, Shi C, Zhuang G, Yin P
OncoTargets and Therapy 2014, 7:779-787
Published Date: 21 May 2014
Manumycin induces apoptosis in prostate cancer cells
Li JG, She MR, Lu CY, Wei SS, Xia PF, Lu ZS, Peng Q
OncoTargets and Therapy 2014, 7:771-777
Published Date: 22 May 2014
Treating advanced non-small-cell lung cancer in Chinese patients: focus on icotinib
Liang JL, Ren XC, Lin Q
OncoTargets and Therapy 2014, 7:761-770
Published Date: 16 May 2014
Clinical potential of bevacizumab in the treatment of metastatic and locally advanced cervical cancer: current evidence
Jackson MW, Rusthoven CG, Fisher CM, Schefter TE
OncoTargets and Therapy 2014, 7:751-759
Published Date: 16 May 2014
Prognostic value of pretreatment serum levels of lactate dehydrogenase in nonmetastatic nasopharyngeal carcinoma: single-site analysis of 601 patients in a highly endemic area
Wei Z, Zeng X, Xu J, Duan X, Xie Y
OncoTargets and Therapy 2014, 7:739-749
Published Date: 15 May 2014
Investigation and analysis of oncologists' knowledge of morphine usage in cancer pain treatment
Liu W, Xie S, Yue L, Liu J, Woo SML, Liu W, Miller AR, Zhang J, Huang L, Zhang L
OncoTargets and Therapy 2014, 7:729-737
Published Date: 13 May 2014
Clinical response to sunitinib as a multitargeted tyrosine-kinase inhibitor (TKI) in solid cancers: a review of clinical trials
Kim S, Ding W, Zhang L, Tian W, Chen S
OncoTargets and Therapy 2014, 7:719-728
Published Date: 12 May 2014
Considering the role of radiation therapy for gastrointestinal stromal tumor
Corbin KS, Kindler HL, Liauw SL
OncoTargets and Therapy 2014, 7:713-718
Published Date: 12 May 2014
IL-17A (-197G/A) and IL-17F (7488T/C) gene polymorphisms and cancer risk in Asian population: a meta-analysis
Dai W, Zhou Q, Tan X, Sun C
OncoTargets and Therapy 2014, 7:703-711
Published Date: 13 May 2014
Antitumor activity of sorafenib and imatinib in a patient with thymic carcinoma harboring c-KIT exon 13 missense mutation K642E
Catania C, Conforti F, Spitaleri G, Barberis M, Preda L, Noberasco C, Lazzari C, Toffalorio F, de Marinis F, Manzotti M, De Pas TM
OncoTargets and Therapy 2014, 7:697-702
Published Date: 8 May 2014
Quality of life assessment in advanced cancer patients treated at home, an inpatient unit, and a day care center
Leppert W, Majkowicz M, Forycka M, Mess E, Zdun-Ryzewska A
OncoTargets and Therapy 2014, 7:687-695
Published Date: 8 May 2014
Renal malignant solitary fibrous tumor with single lymph node involvement: report of unusual metastasis and review of the literature
Mearini E, Cochetti G, Barillaro F, Fatigoni S, Roila F
OncoTargets and Therapy 2014, 7:679-685
Published Date: 8 May 2014
Transcriptional targeting of sphingosine-1- phosphate receptor S1P2 by epigallocatechin- 3-gallate prevents sphingosine-1-phosphate- mediated signaling in macrophage-differentiated HL-60 promyelomonocytic leukemia cells
Chokor R, Lamy S, Annabi B
OncoTargets and Therapy 2014, 7:667-677
Published Date: 7 May 2014
Primary small-cell neuroendocrine carcinoma of the male breast: a rare case report with review of the literature
Jiang J, Wang GX, Lv L, Liu CG, Liang X, Zhao HD
OncoTargets and Therapy 2014, 7:663-666
Published Date: 6 May 2014
Exome sequencing reveals a potential mutational trajectory and treatments for a specific pancreatic cancer patient
Cotterell J
OncoTargets and Therapy 2014, 7:655-662
Published Date: 3 May 2014
Stage-dependent prognostic impact of molecular signatures in clear cell renal cell carcinoma
Weber T, Meinhardt M, Zastrow S, Wienke A, Erdmann K, Hofmann J, Fuessel S, Wirth MP
OncoTargets and Therapy 2014, 7:645-654
Published Date: 2 May 2014
Involvement of c-KIT mutation in the development of gastrointestinal stromal tumors through proliferation promotion and apoptosis inhibition
Ma YY, Yu S, He XJ, Xu Y, Wu F, Xia YJ, Guo K, Wang HJ, Ye ZY, Zhang W, Tao HQ
OncoTargets and Therapy 2014, 7:637-643
Published Date: 2 May 2014
Two thymus-related autoimmune disorders: a case report and review of the literature
Mirtavoos-Mahyari H, Khosravi A, Esfahani-Monfared Z, Shadmehr MB
OncoTargets and Therapy 2014, 7:633-636
Published Date: 10 May 2014
Health behaviors and quality of life in Chinese survivors of cervical cancer: a retrospective study
Nie SX, Gao CQ
OncoTargets and Therapy 2014, 7:627-632
Published Date: 23 April 2014
Clinical utility of circulating tumor cell counting through CellSearch®: the dilemma of a concept suspended in Limbo
Raimondi C, Gradilone A, Naso G, Cortesi E, Gazzaniga P
OncoTargets and Therapy 2014, 7:619-625
Published Date: 17 April 2014
Neuropathic cancer pain: What we are dealing with? How to manage it?
Esin E, Yalcin S
OncoTargets and Therapy 2014, 7:599-618
Published Date: 17 April 2014
MiR-519d represses ovarian cancer cell proliferation and enhances cisplatin-mediated cytotoxicity in vitro by targeting XIAP
Pang Y, Mao H, Shen L, Zhao Z, Liu R, Liu P
OncoTargets and Therapy 2014, 7:587-597
Published Date: 23 April 2014
Microtubule-targeting agents in oncology and therapeutic potential in hepatocellular carcinoma
Loong HH, Yeo W
OncoTargets and Therapy 2014, 7:575-585
Published Date: 16 April 2014
Protein expression of programmed death 1 ligand 1 and ligand 2 independently predict poor prognosis in surgically resected lung adenocarcinoma
Zhang Y, Wang L, Li Y, Pan Y, Wang R, Hu H, Li H, Luo X, Ye T, Sun Y, Chen H
OncoTargets and Therapy 2014, 7:567-573
Published Date: 12 April 2014
Hypofractionated helical tomotherapy (75 Gy at 2.5 Gy per fraction) for localized prostate cancer: long-term analysis of gastrointestinal and genitourinary toxicity
Kong M, Hong SE, Chang SG
OncoTargets and Therapy 2014, 7:553-566
Published Date: 10 April 2014
PIK3CA mutations define favorable prognostic biomarkers in operable breast cancer: a systematic review and meta-analysis
Liu YR, Jiang YZ, Zuo WJ, Yu KD, Shao ZM
OncoTargets and Therapy 2014, 7:543-552
Published Date: 10 April 2014
Characterization of a fusion protein of RGD4C and the ß-lactamase variant for antibody-directed enzyme prodrug therapy
Zhou XL, Wang H, Shi PJ, Meng AM
OncoTargets and Therapy 2014, 7:535-541
Published Date: 10 April 2014
Micro-ribonucleic acid expression profiling and bioinformatic target gene analyses in laryngeal carcinoma
Lu ZM, Lin YF, Jiang L, Chen LS, Luo XN, Song XH, Chen SH, Zhang SY
OncoTargets and Therapy 2014, 7:525-533
Published Date: 5 April 2014
Primary concomitant EGFR T790M mutation predicted worse prognosis in non-small cell lung cancer patients
Li H, Hu H, Wang R, Pan Y, Wang L, Li Y, Zhang Y, Ye T, Zhang Y, Li B, Shen L, Sun Y, Chen H
OncoTargets and Therapy 2014, 7:513-524
Published Date: 3 April 2014
Role of capecitabine in treating metastatic colorectal cancer in Chinese patients
Wang F, Wang FH, Bai L, Xu RH
OncoTargets and Therapy 2014, 7:501-511
Published Date: 2 April 2014
Potential of antibody–drug conjugates and novel therapeutics in breast cancer management
Lianos GD, Vlachos K, Zoras O, Katsios C, Cho WC, Roukos DH
OncoTargets and Therapy 2014, 7:491-500
Published Date: 24 March 2014
Fractionated stereotactic radiosurgery with concurrent temozolomide chemotherapy for locally recurrent glioblastoma multiforme: a prospective cohort study
Greenspoon JN, Sharieff W, Hirte H, Overholt A, Devillers R, Gunnarsson T, Whitton A
OncoTargets and Therapy 2014, 7:485-490
Published Date: 24 March 2014
Downregulation of CD99 and upregulation of human leukocyte antigen class II promote tumor aggravation and poor survival in patients with osteosarcomas
Zhou Q, Xu J, Zhao J, Zhang S, Pan W
OncoTargets and Therapy 2014, 7:477-484
Published Date: 24 March 2014
Retreatment with bevacizumab in patients with gynecologic malignancy is associated with clinical response and does not increase morbidity
Laskey RA, Richard SD, Smith AL, Lin JF, Beck TL, Lesnock JL, Kelley JL 3rd, Olawaiye AB, Sukumvanich P, Krivak TC
OncoTargets and Therapy 2014, 7:469-476
Published Date: 21 March 2014
Oncogene mutational profile in nasopharyngeal carcinoma
Zhang ZC, Fu S, Wang F, Wang HY, Zeng YX, Shao JY
OncoTargets and Therapy 2014, 7:457-467
Published Date: 20 March 2014
Clusterin: a key player in cancer chemoresistance and its inhibition
Koltai T
OncoTargets and Therapy 2014, 7:447-456
Published Date: 20 March 2014
Cancer cell-oriented migration of mesenchymal stem cells engineered with an anticancer gene (PTEN): an imaging demonstration
Yang ZS, Tang XJ, Guo XR, Zou DD, Sun XY, Feng JB, Luo J, Dai LJ, Warnock GL
OncoTargets and Therapy 2014, 7:441-446
Published Date: 17 March 2014
Gastrointestinal tract metastasis from tubulolobular carcinoma of the breast: a case report and review of the literature
Wang GX, Wang TJ, Jiang J, Zhou LY, Zhao HD
OncoTargets and Therapy 2014, 7:435-440
Published Date: 18 March 2014
Is combination of neutrophil to lymphocyte ratio and platelet lymphocyte ratio a useful predictor of postoperative survival in patients with esophageal squamous cell carcinoma?
Tanoglu A, Karagoz E, Yiyit N, Berber U
OncoTargets and Therapy 2014, 7:433-434
Published Date: 14 March 2014
Additive effect by combination of Akt inhibitor, MK-2206, and PDGFR inhibitor, tyrphostin AG 1296, in suppressing anaplastic thyroid carcinoma cell viability and motility
Che HY, Guo HY, Si XW, You QY, Lou WY
OncoTargets and Therapy 2014, 7:425-432
Published Date: 14 March 2014
A rehabilitation program for lung cancer patients during postthoracotomy chemotherapy
Hoffman AJ, Brintnall RA, von Eye A, Jones LW, Alderink G, Patzelt LH, Brown JK
OncoTargets and Therapy 2014, 7:415-423
Published Date: 10 March 2014
Clinical effectiveness, toxicity, and failure patterns of helical tomotherapy for postoperative oral cavity cancer patients
Hsieh CH, Shueng PW, Wang LY, Liao LJ, Lin YC, Kuo YS, Lo WC, Tseng CF, Tien HJ, Chou HL, Hsieh YP, Wu LJ, Chen YJ
OncoTargets and Therapy 2014, 7:405-414
Published Date: 10 March 2014
Clinical efficacy and safety of imatinib in the management of Ph+ chronic myeloid or acute lymphoblastic leukemia in Chinese patients
Zhu Y, Qian SX
OncoTargets and Therapy 2014, 7:395-404
Published Date: 6 March 2014
The predictive role of pretreatment epidermal growth factor receptor T790M mutation on the progression-free survival of tyrosine-kinase inhibitor-treated non-small cell lung cancer patients: a meta-analysis
Ding D, Yu YF, Li ZM, Niu XM, Lu S
OncoTargets and Therapy 2014, 7:387-393
Published Date: 6 March 2014
Development of anaplastic lymphoma kinase (ALK) inhibitors and molecular diagnosis in ALK rearrangement-positive lung cancer
Iwama E, Okamoto I, Harada T, Takayama K, Nakanishi Y
OncoTargets and Therapy 2014, 7:375-385
Published Date: 5 March 2014
Clinical impact of targeted therapies in patients with metastatic clear-cell renal cell carcinoma
Nerich V, Hugues M, Paillard MJ, Borowski L, Nai T, Stein U, Nguyen Tan Hon T, Montcuquet P, Maurina T, Mouillet G, Kleinclauss F, Pivot X, Limat S, Thiery-Vuillemin A
OncoTargets and Therapy 2014, 7:365-374
Published Date: 27 February 2014
Cyclooxygenase-2 inhibitor is a robust enhancer of anticancer agents against hepatocellular carcinoma multicellular spheroids
Cui J, Guo YH, Zhang HY, Jiang LL, Ma JQ, Wang WJ, Wang MC, Yang CC, Nan KJ, Song LP
OncoTargets and Therapy 2014, 7:353-363
Published Date: 24 February 2014
ABCC4 is required for cell proliferation and tumorigenesis in non-small cell lung cancer
Zhao X, Guo Y, Yue W, Zhang L, Gu M, Wang Y
OncoTargets and Therapy 2014, 7:343-351
Published Date: 21 February 2014
Isotype-specific inhibition of the phosphatidylinositol-3-kinase pathway in hematologic malignancies
Castillo JJ, Iyengar M, Kuritzky B, Bishop KD
OncoTargets and Therapy 2014, 7:333-342
Published Date: 21 February 2014
miR-7 inhibits colorectal cancer cell proliferation and induces apoptosis by targeting XRCC2
Xu K, Chen Z, Qin C, Song X
OncoTargets and Therapy 2014, 7:325-332
Published Date: 20 February 2014
Recent advances in the ARID family: focusing on roles in human cancer
Lin C, Song W, Bi XY, Zhao JJ, Huang Z, Li ZY, Zhou JG, Cai JQ, Zhao H
OncoTargets and Therapy 2014, 7:315-324
Published Date: 18 February 2014
Synergism from the combination of ulinastatin and curcumin offers greater inhibition against colorectal cancer liver metastases via modulating matrix metalloproteinase-9 and E-cadherin expression
Shen F, Cai WS, Li JL, Feng Z, Liu QC, Xiao HQ, Cao J, Xu B
OncoTargets and Therapy 2014, 7:305-314
Published Date: 18 February 2014
Prognostic significance of the combined expression of neutral endopeptidase and dipeptidyl peptidase IV in intrahepatic cholangiocarcinoma patients after surgery resection
Zhu JY, Guo XD, Qiu BA, Li ZY, Xia NX, Yang YX, Liu P
OncoTargets and Therapy 2014, 7:297-304
Published Date: 17 February 2014
Axitinib for preoperative downstaging of renal cell carcinoma with sarcomatoid differentiation and direct invasion of the duodenum and inferior vena cava: a case report
Yuki H, Kamai T, Kubota K, Abe H, Nishihara D, Mizuno T, Masuda A, Betsunoh H, Yashi M, Fukabori Y, Yoshida KI
OncoTargets and Therapy 2014, 7:289-295
Published Date: 15 February 2014
The value of radiotherapy in breast cancer patients with isolated ipsilateral supraclavicular lymph node metastasis without distant metastases at diagnosis: a retrospective analysis of Chinese patients
Wu SG, Sun JY, Zhou J, Li FY, Lin Q, Lin HX, He ZY
OncoTargets and Therapy 2014, 7:281-288
Published Date: 15 February 2014
Nickel nanoparticle-induced dose-dependent cyto-genotoxicity in human breast carcinoma MCF-7 cells
Ahamed M, Alhadlaq HA
OncoTargets and Therapy 2014, 7:269-280
Published Date: 14 February 2014
The relationship between intervention in the CD40 signal pathway and choroidal neovascularization
Zhang P, Su Y, Liu F
OncoTargets and Therapy 2014, 7:263-267
Published Date: 14 February 2014
Role of erlotinib in the targeted treatment of non-small-cell lung cancer in Chinese patients
Li W, Zhou F, Zhou C
OncoTargets and Therapy 2014, 7:253-261
Published Date: 13 February 2014
Targeted treatment of head and neck squamous-cell carcinoma: potential of lapatinib
Gandhi MD, Agulnik M
OncoTargets and Therapy 2014, 7:245-251
Published Date: 13 February 2014
Treating malignant glioma in Chinese patients: update on temozolomide
Chang L, Su J, Jia X, Ren H
OncoTargets and Therapy 2014, 7:235-244
Published Date: 12 February 2014
Mechanism of action and clinical activity of tasquinimod in castrate-resistant prostate cancer
Gupta N, Al Ustwani O, Shen L, Pili R
OncoTargets and Therapy 2014, 7:223-234
Published Date: 12 February 2014
Midazolam induces apoptosis in MA-10 mouse Leydig tumor cells through caspase activation and the involvement of MAPK signaling pathway
So EC, Lin YX, Tseng CH, Pan BS, Cheng KS, Wong KL, Hao LJ, Wang YK, Huang BM
OncoTargets and Therapy 2014, 7:211-221
Published Date: 13 February 2014
Ipilimumab in the treatment of metastatic melanoma: management of adverse events
Della Vittoria Scarpati G, Fusciello C, Perri F, Sabbatino F, Ferrone S, Carlomagno C, Pepe S
OncoTargets and Therapy 2014, 7:203-209
Published Date: 19 February 2014
Dichloroacetate modulates cytokines toward T helper 1 function via induction of the interleukin-12–interferon-γ pathway
Badr MM, Qinna NA, Qadan F, Matalka KZ
OncoTargets and Therapy 2014, 7:193-201
Published Date: 7 February 2014
Nab-paclitaxel: potential for the treatment of advanced pancreatic cancer
Al-Hajeili M, Azmi AS, Choi M
OncoTargets and Therapy 2014, 7:187-192
Published Date: 4 February 2014
Omacetaxine mepesuccinate in the treatment of intractable chronic myeloid leukemia
Chen Y, Li S
OncoTargets and Therapy 2014, 7:177-186
Published Date: 31 January 2014
Thoracotomy in refractory gestational trophoblastic neoplasia with lung metastasis after normalization of serum beta human chorionic gonadotropin (β-hCG) with salvage chemotherapy
Feng FZ, Hu HY, Wu L, Ren T, Wan XR, Xiang Y
OncoTargets and Therapy 2014, 7:171-176
Published Date: 29 January 2014
Effective use of everolimus as salvage chemotherapy for ovarian clear cell carcinoma: a case report
Takatori E, Shoji T, Miura Y, Takada A, Takeuchi S, Sugiyama T
OncoTargets and Therapy 2014, 7:165-169
Published Date: 29 January 2014
Triple-negative breast cancer risk in women is defined by the defect of estrogen signaling: preventive and therapeutic implications
Suba Z
OncoTargets and Therapy 2014, 7:147-164
Published Date: 23 January 2014
Combined overexpression of HIVEP3 and SOX9 predicts unfavorable biochemical recurrence- free survival in patients with prostate cancer
Qin GQ, He HC, Han ZD, Liang YX, Yang SB, Huang YQ, Zhou L, Fu H, Li JX, Jiang FN, Zhong WD
OncoTargets and Therapy 2014, 7:137-146
Published Date: 24 January 2014
Clinical value of serum human epididymis protein 4 assay in the diagnosis of ovarian cancer: a meta-analysis [Erratum]
Yang Z, Wei C, Luo Z, Li L
OncoTargets and Therapy 2014, 7:135-136
Published Date: 23 January 2014
Therapeutic targeting of Neu1 sialidase with oseltamivir phosphate (Tamiflu®) disables cancer cell survival in human pancreatic cancer with acquired chemoresistance
O’Shea LK, Abdulkhalek S, Allison S, Neufeld RJ, Szewczuk MR
OncoTargets and Therapy 2014, 7:117-134
Published Date: 16 January 2014
Clear cell carcinoma of the uterine cervix: clinical characteristics and feasibility of fertility-preserving treatment
Jiang X, Jin Y, Li Y, Huang HF, Wu M, Shen K, Pan LY
OncoTargets and Therapy 2014, 7:111-116
Published Date: 9 January 2014
Effect of onion flavonoids on colorectal cancer with hyperlipidemia: an in vivo study
He Y, Jin H, Gong W, Zhang C, Zhou A
OncoTargets and Therapy 2014, 7:101-110
Published Date: 8 January 2014
Comparison of concurrent chemoradiotherapy followed by radical surgery and high-dose-rate intracavitary brachytherapy: a retrospective study of 240 patients with FIGO stage IIB cervical carcinoma
Wang N, Li WW, Li JP, Liu JY, Zhou YC, Zhang Y, Hu J, Huang YH, Chen Y, Wei LC, Shi M
OncoTargets and Therapy 2014, 7:91-100
Published Date: 6 January 2014
The long-term survival of a thymic carcinoma patient treated with S-1: a case report and literature review
Tanaka H, Morimoto T, Taima K, Tanaka Y, Nakamura K, Hayashi A, Kurose A, Okumura K, Takanashi S
OncoTargets and Therapy 2014, 7:87-90
Published Date: 27 December 2013
High expression of Sonic Hedgehog signaling pathway genes indicates a risk of recurrence of breast carcinoma
Jeng KS, Sheen IS, Jeng WJ, Yu MC, Hsiau HI, Chang FY
OncoTargets and Therapy 2014, 7:79-86
Published Date: 27 December 2013
Ocular side effects of biological agents in oncology: what should the clinician be aware of?
Hager T, Seitz B
OncoTargets and Therapy 2014, 7:69-77
Published Date: 24 December 2013
Uncovering the role of p53 splice variants in human malignancy: a clinical perspective
Surget S, Khoury MP, Bourdon JC
OncoTargets and Therapy 2014, 7:57-68
Published Date: 19 December 2013
Targeted therapy for Hodgkin lymphoma and systemic anaplastic large cell lymphoma: focus on brentuximab vedotin
Chen X, Soma LA, Fromm JR
OncoTargets and Therapy 2014, 7:45-56
Published Date: 19 December 2013
Emerging concepts in pancreatic cancer medicine: targeting the tumor stroma
Neesse A, Krug S, Gress TM, Tuveson DA, Michl P
OncoTargets and Therapy 2014, 7:33-43
Published Date: 18 December 2013
hnRNP C1/C2 and Pur-beta proteins mediate induction of senescence by oligonucleotides homologous to the telomere overhang
Mulnix RE, Pitman RT, Retzer A, Bertram C, Arasi K, Crees Z, Girard J, Uppada SB, Stone AL, Puri N
OncoTargets and Therapy 2014, 7:23-32
Published Date: 18 December 2013
Management of cytopenias in patients with myelofibrosis treated with ruxolitinib and effect of dose modifications on efficacy outcomes
Verstovsek S, Gotlib J, Gupta V, Atallah E, Mascarenhas J, Quintas-Cardama A, Sun W, Sarlis NJ, Sandor V, Levy RS, Kantarjian HM, Mesa RA
OncoTargets and Therapy 2014, 7:13-21
Published Date: 17 December 2013
The -159C/T polymorphism in the CD14 gene and cancer risk: a meta-analysis
Zhou W, Jia L, Guo S, Hu Q, Shen Y, Li N
OncoTargets and Therapy 2014, 7:5-12
Published Date: 10 December 2013
Primary malignant fibrous histiocytoma of the renal pelvis: a 78-month follow-up case report
Chen YB, Rao D, Zhu H, Yu H, Yang SK
OncoTargets and Therapy 2014, 7:1-3
Published Date: 17 December 2013